Posted by Michael Wonder on 21 May 2020
Coronavirus revives debate over drug pricing
21 May 2020 - Lure of profits laid groundwork for some COVID-19 treatments, though may not determine who finds a cure.
Not long ago, drug companies had a bull’s-eye on their ticker symbols. Sky-high prices for lifesaving drugs and the opioid crisis had made them the country’s least-liked industry.
Democratic presidential candidates were one-upping each other with promises to rein in prices, while President Trump mulled similar plans.
